Dr. Limin Chen, affiliate scientist with the University of Torontoa and also a professor with the Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), now is the director and chief scientific officer of the center for transfusion transmitted diseases, Institute of Blood Transfusion (IBT), CAMS/PUMC, Member of the American Association for Studies of Liver Diseases (AASLD) and Canadian Association for Studies of Liver (CASL). He obtained his MD, MSc in biochemistry and molecular biology in China, PhD in molecular genetics at the University of Toronto. Dr. Chen obtained his postdoctoral training both at the Merck Research Laboratories and at the Harvard Medical School .
Currently Dr. Chen’s research focuses on the virus-host interaction of the hepatitis viruses, especially HCV and HBV. He pioneered the work on identification of the response signature of HCV non-response to interferon treatment and proposed a novel mechanism on how HCV exploits host innate immune response to benefit its persistent infection and resistance to interferon-based therapy.
Dr. (Professor) A K Prasad, FRSM (London), PhD (Leeds), FNCCP, FICAAI, FISMCD, FIVS, FIAMPV, FGSI. Former University Prof & HOD, Respiratory Virology, V.Patel Chest Institute, Delhi, Medical Microbiology, Delhi University. Chairman, Influenza Foundation of India,Member Asia Pacific Alliance for the Control of Influenza (APACI) Ltd. President, Indian Virological Society. ( in process of renaming as ACADEMY OF VIROLOGIST)Executive Council Member, Ind. College of Asthma, Allergy & ImmunologyPresident, Biotechnology Society of India,Former President, Indian College of Allergy & Applied Immunology. Former Editor, Indian J. of Allergy & Applied Immunology.Former Short-time Consultant WHO (SEARO) Delhi.